The interaction of patient perception of overmedication with drug compliance and side effects

Journal of General Internal Medicine
B G FinckeA Spiro

Abstract

Little is known about the significance of patient-perceived overmedication. We sought to determine its prevalence and relation to medication compliance, adverse drug reactions, health-related quality of life (HRQOL), and burden of illness. Analysis of self-reported questionnaire data. PATIENTS/PARTICIPANT: There were 1,648 participants in a longitudinal study of male veterans. Participants listed each of their medications with indication, missed doses, adverse reactions, and whether their amount of medication was "too much, the right amount, or too little." The survey included questions about medication adherence, "problems with medications," common symptoms, and screening questions for a number of chronic conditions. We assessed HRQOL with the Multiple Outcomes Study 36-Item Short Form Health Study (SF-36). Of the 1,256 respondents, 1,007 (80%) had taken medication within 4 weeks. Forty (4%) thought they were taking too much. They reported a 1.6-fold increase in prescription medications, a 5-8 fold increase in adverse effects, a 1.5-2 fold decrease in compliance, an increase in each of seven measured symptoms, and a decrease in six of eight SF-36 domains (p < .05 for all comparisons), the exceptions being the mental health and...Continue Reading

References

Aug 17, 1979·JAMA : the Journal of the American Medical Association·M S KramerA R Feinstein
Dec 22, 1975·JAMA : the Journal of the American Medical Association·F E Karch, L Lasagna
Jun 1, 1987·Archives of Internal Medicine·T J IvesR E Gwyther
May 6, 1974·JAMA : the Journal of the American Medical Association·G J CaranasosL E Cluff
Aug 2, 1973·The New England Journal of Medicine·B Blackwell
Nov 1, 1980·Hypertension·R B HaynesJ Mukherjee

❮ Previous
Next ❯

Citations

Jan 1, 2010·Pharmacy World & Science : PWS·June TordoffPauline T Norris
Jan 18, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Martin FortinAlain Vanasse
Mar 4, 2010·The British Journal of Nutrition·Simone EussenCathy Rompelberg
Feb 16, 2002·Journal of Clinical Pharmacy and Therapeutics·X S RenD R Miller
Feb 20, 2002·Clinical Neuropharmacology·Hugo Juárez-OlguínIsmael Lares Asseff
Jul 3, 2010·Journal of Gastroenterology and Hepatology·Daniel R van LangenbergJane M Andrews
Mar 25, 2008·Therapeutics and Clinical Risk Management·Raffaele Antonelli IncalziPierugo Carbonin
Nov 22, 2008·Drugs & Aging·Sönke ArltWolfgang von Renteln-Kruse
Feb 4, 2014·European Journal of Clinical Pharmacology·R A PayneG A Abel
Mar 16, 2000·Journal of General Internal Medicine·B G Petty
Jul 15, 2015·Expert Opinion on Emerging Drugs·Jonathan Tomas Lockwood, Gary Remington
Jul 14, 2010·Neurologia i neurochirurgia polska·Wojciech MasełbasAnna Członkowska
Oct 20, 2005·Pharmacotherapy·Barbara J ZarowitzEdward L Peterson
Mar 6, 2012·The American Journal of Medicine·Ian A ScottCharles A Mitchell
May 17, 2005·American Heart Journal·Ann M BorzeckiDan R Berlowitz
May 18, 2017·Health Economics·Arndt R Reichert, Magdalena A Stroka
Jul 11, 2013·The American Journal of Hospice & Palliative Care·Marco RuizDominique Anwar
Oct 16, 2003·Pharmacoepidemiology and Drug Safety·Johanna UlfvarsonChrister von Bahr
Jan 24, 2008·Journal of Psychiatric Practice·Ahsan Y Khan, M Rafique Shaikh
Aug 6, 2005·The Journal of Nervous and Mental Disease·Michele SpoontDavid B Nelson
Oct 5, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Rupert A Payne
Jul 7, 2019·Orphanet Journal of Rare Diseases·Wojciech MaselbasAnna Czlonkowska
Dec 2, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Ami VyasMarilyn Barbour
Jan 1, 2017·European Journal of Hospital Pharmacy. Science and Practice·Polly DuncanRupert A Payne
Nov 14, 2019·BMC Neurology·Wojciech MasełbasMaciej Niewada
May 26, 2020·Journal of the American Heart Association·Nemin ChenAlvaro Alonso
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N ChernyUNKNOWN Expert Working Group of the European Association of Palliative Care Network
Sep 5, 2021·Journal of Inherited Metabolic Disease·Elodie JacqueletFrance Woimant

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.